Related Experiment Video
Updated: Oct 3, 2025

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications
Giovanni Donato Aquaro1, Elisabetta Corsi2, Giancarlo Todiere1
1Fondazione Toscana G. Monasterio, 56124 Pisa, Italy.
Insights
Cardiac magnetic resonance (CMR) significantly alters diagnoses for left ventricular hypertrophy (LVH) initially suspected via echocardiography or ECG. This advanced imaging improves diagnostic accuracy and reassesses patient prognosis, particularly for hypertrophic cardiomyopathy.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Medicine
Background:
- Left ventricular hypertrophy (LVH) presents diverse etiologies, from secondary forms to severe cardiomyopathies.
- Transthoracic Echocardiography (TTE) and Electrocardiography (ECG) are primary tools for LVH diagnosis.
- Cardiac Magnetic Resonance (CMR) offers precise characterization of LVH type, extent, and severity.
Purpose of the Study:
- To assess the diagnostic and prognostic utility of CMR in patients with suspected LVH.
- To evaluate CMR's role in refining diagnoses made by TTE and/or ECG.
Main Methods:
- CMR imaging was performed on 300 consecutive patients exhibiting TTE and/or ECG signs of LVH.
- Diagnostic discrepancies between initial TTE suspicion and final CMR diagnosis were analyzed.
Main Results:
- CMR altered the initial diagnosis in 42.7% of patients, significantly increasing hypertrophic cardiomyopathy (HCM) detection.
- CMR successfully diagnosed LVH in 82% of cases with initially undetermined TTE findings.
- CMR identified HCM in 80% of patients with ECG criteria for LVH but normal echocardiography, and reclassification impacted survival risk assessment.
Conclusions:
- CMR significantly reclassifies LVH diagnoses initially suggested by echocardiography, particularly identifying HCM.
- CMR is crucial for characterizing LVH when detected by echocardiography or suspected via ECG.
- The study underscores CMR's value in improving diagnostic accuracy and prognostic stratification for LVH.
Background:
Left ventricular hypertrophy (LVH) may be due to different causes, ranging from benign secondary forms to severe cardiomyopathies. Transthoracic Echocardiography (TTE) and ECG are the first-level examinations for LVH diagnosis. Cardiac magnetic resonance (CMR) accurately defines LVH type, extent and severity.
Objectives:
to evaluate the diagnostic and prognostic role of CMR in patients with TTE and/or ECG evidence of LVH.
Methods:
We performed CMR in 300 consecutive patients with echocardiographic and/or ECG signs of LVH.
Results:
Overall, 275 patients had TTE evidence of LVH, with initial suspicion of hypertrophic cardiomyopathy (HCM) in 132 (44%), cardiac amyloidosis in 41 (14%), hypertensive LVH in 48 (16%), aortic stenosis in 4 (1%), and undetermined LVH in 50 (16%). The initial echocardiographic diagnostic suspicion of LVH was confirmed in 172 patients (57.3%) and changed in 128 patients (42.7%, p < 0.0001): the diagnosis of HCM increased from 44% to 71% of patients; hypertensive and undetermined LVH decreased significantly (respectively to 4% and 5%). CMR allowed for a diagnosis in 41 out of 50 (82%) patients with undetermined LVH at TTE. CMR also identified HCM in 17 out of 25 patients with apparently normal echocardiography but with ECG criteria for LVH. Finally, the reclassification of the diagnosis by CMR was associated with a change in survival risk of patients: after CMR reclassification, no events occurred in patients with undetermined or hypertensive LVH.
Conclusions:
CMR changed echocardiographic suspicion in almost half of patients with LVH. In the subgroup of patients with abnormal ECG, CMR identified LVH (particularly HCM) in 80% of patients. This study highlights the indication of CMR to better characterize the type, extent and severity of LVH detected at echocardiography and suspected with ECG.
More Related Videos
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies